Nvidias Blockbuster Quarter Reveals a 200 Billion Edge Computing Opportunity Amid China Market Concession SpaceXs Starship Test Flight Lifts Off on Second Attempt After Day Delay Earnings Season Heats Up Key Reports and Analyst Estimates to Watch Align Technology Plans 200 Million Manufacturing Facility in India Microns 2B Virginia Expansion Marks Milestone for Advanced DRAM Production in the US Wall Street Edges Higher as MidEast Peace Hopes Boost Investor Sentiment ATLN Q4 2025 Earnings Significant EPS Miss Weighs on Stock Axsome Therapeutics Q1 2026 Earnings WiderThanExpected Loss as Pipeline Progress Takes Center Stage Hennessy Advisors Q1 2026 Earnings EPS of 024 Reported Bond Price Edges Lower PLAYSTUDIOS MYPS Q1 2026 Earnings Deeper Loss Than Anticipated Sends Stock Higher AMCX Q1 2026 Earnings EPS Misses Estimates Amid Continued CordCutting Headwinds Ark Restaurants Q4 2025 Earnings Net Loss Reported No Revenue Detail Disclosed Dana Incorporated DAN Gains 169 as Shares Test Midrange Territory Lucid Diagnostics LUCD Surges 7 as Momentum Builds Near Key Resistance Hancock Whitney HWC Edges Higher in Quiet Trading Testing Middle of Range Reinsurance Group of America 575 FixedtoFloating Debentures RZB Hold Steady Near 2530 Yield Dynamics in Focus Revvity Inc RVTY Faces Headwinds Navigating Support and Resistance Sebi Uncovers PumpandDump Scheme Across 82 SME Stocks Rs 2025 Crore Impounded SY Q1 2026 Earnings NarrowerThanExpected Loss Fails to Lift Sentiment as Revenue Remains Under Wraps TDS Shares Decline Sharply as Selling Pressure Intensifies RLMD Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues RD Investment DOX Q1 2026 Earnings EPS Slightly Misses Estimates Stock Edges Lower LNC Q1 2026 Earnings EPS Surpasses Estimates Despite Absent Revenue Disclosure EXP Q1 2026 Earnings Powerful EPS Beat Highlights Cost Discipline Amid Subdued Demand NTRSO Q1 2026 Earnings Northern Trust Beats EPS Estimates by 1435 Shares Dip Slightly HWCPZ Q1 2026 Earnings Slight EPS Beat Highlights Steady Performance GALT Q1 2026 Earnings WiderThanExpected Loss as ClinicalStage Biotech Continues RD Spend